We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
-0.87%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$46.4B
AUM Growth
+$701M
Cap. Flow
+$2.34B
Cap. Flow %
5.06%
Top 10 Hldgs %
14.53%
Holding
2,237
New
170
Increased
888
Reduced
909
Closed
187

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$197M
2
DECK icon
Deckers Outdoor
DECK
+$179M
3
DXCM icon
DexCom
DXCM
+$156M
4
TER icon
Teradyne
TER
+$154M
5
XOM icon
ExxonMobil
XOM
+$153M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$163M
2
WING icon
Wingstop
WING
+$130M
3
NOW icon
ServiceNow
NOW
+$108M
4
GDDY icon
GoDaddy
GDDY
+$94.2M
5
VRT icon
Vertiv
VRT
+$80M

Sector Composition

Rank Sector Weight
1 Technology 19.5%
2 Healthcare 16.86%
3 Financials 13.55%
4 Consumer Discretionary 9.41%
5 Industrials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LTBR icon
1951
Lightbridge
LTBR
$234M
$1.94K ﹤0.01%
260
-83
-24% -$738
CALM icon
1952
Cal-Maine
CALM
$3.47B
$1.91K ﹤0.01%
21
WLFC icon
1953
Willis Lease Finance
WLFC
$1.14B
$1.9K ﹤0.01%
+36
New +$2.29K
USCB icon
1954
USCB Financial Holdings
USCB
$427M
$1.86K ﹤0.01%
100
+12
+14% +$224
PLPC icon
1955
Preformed Line Products
PLPC
$1.97B
$1.82K ﹤0.01%
13
-5
-28% -$680
RLGT icon
1956
Radiant Logistics
RLGT
$466M
$1.81K ﹤0.01%
295
+34
+13% +$230
NWG icon
1957
NatWest
NWG
$73.6B
$1.8K ﹤0.01%
151
EWTX icon
1958
Edgewise Therapeutics
EWTX
$4.74B
$1.76K ﹤0.01%
80
-27
-25% -$708
CARM
1959
DELISTED
Carisma Therapeutics
CARM
$1.75K ﹤0.01%
5,629
+656
+13% +$291
CCCC icon
1960
C4 Therapeutics
CCCC
$421M
$1.71K ﹤0.01%
+1,069
New +$3.19K
AXGN icon
1961
Axogen
AXGN
$2.42B
$1.7K ﹤0.01%
92
-16
-15% -$289
NOTE
1962
DELISTED
FiscalNote
NOTE
$1.69K ﹤0.01%
174
+23
+15% +$346
NCSM
1963
DELISTED
NCS Multistage Holdings
NCSM
$1.68K ﹤0.01%
48
+28
+140% +$830
AEYE icon
1964
AudioEye
AEYE
$103M
$1.67K ﹤0.01%
150
WHWK
1965
Whitehawk Therapeutics
WHWK
$233M
$1.66K ﹤0.01%
930
-3,794
-80% -$9.91K
VTSI icon
1966
VirTra
VTSI
$33.1M
$1.64K ﹤0.01%
+402
New +$2.4K
GOCO
1967
DELISTED
GoHealth
GOCO
$1.61K ﹤0.01%
+131
New +$2K
CABO icon
1968
Cable One
CABO
$107M
$1.59K ﹤0.01%
6
-160
-96% -$46.8K
USLM icon
1969
United States Lime & Minerals
USLM
$3.39B
$1.59K ﹤0.01%
+18
New +$1.87K
RMNI icon
1970
Rimini Street
RMNI
$430M
$1.57K ﹤0.01%
+451
New +$1.46K
CURI icon
1971
CuriosityStream
CURI
$167M
$1.57K ﹤0.01%
585
-1,037
-64% -$2.52K
BOW
1972
Bowhead Specialty Holdings
BOW
$1.11B
$1.54K ﹤0.01%
38
+22
+138% +$749
NOTV
1973
DELISTED
Inotiv
NOTV
$1.52K ﹤0.01%
688
+26
+4% +$95
SGC icon
1974
Superior Group of Companies
SGC
$199M
$1.51K ﹤0.01%
138
+16
+13% +$225
GRPN icon
1975
Groupon
GRPN
$761M
$1.5K ﹤0.01%
80
+78
+3,900% +$988

Similar funds

Federated Hermes's Q1 2025 Portfolio in Review

As of Q1 2025, Federated Hermes held 2,237 positions worth $46.4B, up 1.5% from $45.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Federated Hermes deployed $2.34B of net new capital in Q1 2025, opening 170 new positions and adding to 888 existing holdings. Its largest new stake was Zscaler: 283,095 shares worth $56.2M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $163M trimmed.

  • Federated Hermes's largest Q1 2025 buy was Zscaler: 283,095 shares worth $56.2M.
  • Federated Hermes added most to Amgen in Q1 2025, an estimated $197M increase.
  • Federated Hermes's biggest Q1 2025 reduction was Gilead Sciences, cutting an estimated $163M.
  • Federated Hermes fully exited New Fortress Energy in Q1 2025, selling an estimated $31.4M.
  • Federated Hermes's ten largest holdings make up 15% of its $46.4B portfolio in Q1 2025.
  • Federated Hermes opened 170 new positions and closed 187 in Q1 2025.
  • Federated Hermes's portfolio value rose 1.5% quarter-over-quarter to $46.4B.

Based on Federated Hermes's 13F filing for Q1 2025, filed 8 May 2025.